CDC Updates RSV Vaccination Recommendation for Adults
网页2024年6月26日 · Today, CDC updated its recommendation for the use of Respiratory Syncytial Virus (RSV) vaccines in people ages 60 and older. For this upcoming respiratory virus season, CDC recommends: Everyone ages 75 and older receive the RSV vaccine.
FDA approves first vaccine for RSV, a moment six decades in the ... - CNN
网页2023年5月3日 · After a 60-year scientific quest, the world has its first vaccine to protect against respiratory syncytial virus, or RSV – and more are on the way.
FDA Approves First Respiratory Syncytial Virus (RSV) Vaccine
网页2023年5月4日 · Today, the U.S. Food and Drug Administration approved Arexvy, the first respiratory syncytial virus (RSV) vaccine approved for use in the United States. Arexvy is approved for the prevention of...
FDA advisers recommend world's first RSV vaccines, from ... - NBC News
网页2023年3月1日 · An FDA advisory committee has recommended that the agency approve two RSV vaccines for older people, one from Pfizer and another from GSK.
FDA approves Moderna’s mRNA RSV vaccine for older adults
网页2024年5月31日 · The US Food and Drug Administration has approved another vaccine that can help protect older people from respiratory syncytial virus, known as RSV. The shot, made by Moderna and sold under the...
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Older - The …
网页2023年5月31日 · The Food and Drug Administration on Wednesday approved Pfizer’s vaccine against the respiratory syncytial virus, or R.S.V., for adults age 60 and older, the second approval granted for shots ...
RSV: What to know about the latest surge and treatments : NPR
网页2022年11月2日 · Here are answers to some of the most common questions about the RSV infection, who is most at risk and what might be causing this year's outbreak. Why might RSV be particularly bad this year?
The race to an RSV vaccine is nearly over as shots await FDA ... - NBC News
网页2023年2月16日 · RSV cases spiked dramatically in the U.S. earlier this winter, which overwhelmed children's hospitals — a reminder of the virus's threat. Since then, the pharmaceutical race to get vaccines to...
FDA advisers vote in favor of approval for RSV vaccines for older ... - CNN
网页2023年2月28日 · CNN — Over the course of a two-day meeting, vaccine advisers to the US Food and Drug Administration voted in favor of approval for RSV vaccines for adults over the age of 60. The vaccine...
CDC and FDA Expedite the Availability of Additional Doses of New RSV …
网页2023年11月16日 · Today, CDC announced the release of more than 77,000 additional doses of Beyfortus™ (nirsevimab-alip (100 mg), a long-acting monoclonal antibody designed to protect infants against severe respiratory syncytial virus (RSV) disease.
跳至内容